For moderate to severe rheumatoid arthritis (RA) in adult TNFi‑IR patients1
For active psoriatic arthritis (PsA) in adult TNFi‑IR patients1
For active ankylosing spondylitis (AS)
in adult TNFi‑IR patients1

Abbvie's
commitment to
exceptional
access and patient
support

Get started with the Enrollment & Prescription Form

Get started with the Enrollment & Prescription Form

Confidence in access

ACCESS AVAILABLE THROUGH INSURANCE OR
RINVOQ COMPLETE

more than 9 out of 10

Commercial patients
have access to RINVOQ AS2


Encourage your patients to enroll in

Encourage your patients to enroll in

 

Access is available as of April 2022 and through commercial insurance, or through RINVOQ Complete if coverage is denied.*

Affordability: Eligible commercially insured patients may pay as little as $5 per month.

Access: No charge for eligible patients experiencing initial insurance delay or denial for
up to 24 months*

 

Exceptional 1:1 patient experience when your patients enroll in RINVOQ Complete

GET STARTED WITH THE ENROLLMENT & PRESCRIPTION FORM

*Commercial insurance coverage varies by type and plan. Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ® (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ® (upadacitinib) at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.

Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html

TWO PRODUCTS.
ONE EXCEPTIONAL PATIENT EXPERIENCE.

RINVOQ® Complete
HUMIRA® COMPLETE

Nurse
Ambassadors*

Empower patients

Our Nurse Ambassadors are the heart of RINVOQ Complete and HUMIRA Complete

Nurse Ambassadors provide 1:1 support to help patients start and stay on track with their prescribed treatment plan, including:

  • Committed to answering questions throughout the experience to help limit treatment disruptions.
  • Answer patients’ insurance questions, and connect them with additional insurance expertise.

Insurance
SPECIALISTS

Insurance support when needed

Insurance Specialists:

  • Resource with expertise on Medicare and commercial plans at a national, local, and program level so that they can educate on potential options to consider based on each patient’s unique financial situation.
  • Can educate on payer prior authorization and appeal processes so you can determine the best access option for each patient’s unique situation.

ACCESS & SAVINGS

Help with access & treatment affordability

Complete can help your commercially insured patients save: 

  • With the Complete Savings Card, your eligible commercially insured patients may pay as little as $5 per month.
  • RINVOQ Complete may help eligible commercially insured patients experiencing initial coverage delays or denials access their prescribed therapy at no charge while coverage is established. Eligibility criteria apply.
  • Please see Terms and Conditions found in Footnotes and Definitions.

THE COMPLETE APP

Help patients
track treatment

The RINVOQ Complete and HUMIRA Complete apps are designed to help patients stay on track with their treatment plan by helping them:

  • Access additional resources, including savings card for those who are eligible.
  • Set up medication reminders.
  • Log symptoms.
  • Log medication lot number and medication expiration date.
Download on the App Store
Get it on Google Play

ADDITIONAL RESOURCES

Ongoing Education:

  • RINVOQ Complete builds on HUMIRA Complete and continues to provide helpful information and resources through life changes that can affect insurance coverage, including open enrollment and job status changes.

RINVOQ Specialty Pharmacy Resources:

  • RINVOQ is broadly available through open distribution, and prescriptions may be sent to the specialty pharmacy of the patient's choosing.
  • In addition to open distribution, contracted specialty pharmacies have the capability to:

    • Help facilitate enrollment into RINVOQ Complete
    • Inform patients and your staff if the RINVOQ prescription must be transferred to another pharmacy mandated by the patient's insurance
    • Provide education on insurance process requirements

Empowering Patients
Nurse Ambassadors, In Their Own Words

Have questions or need support over the phone?

Call 1-877-COMPLETE
(1-800-274-6867)

*Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) or HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com for RINVOQ® patients and HUMIRASavingsCard.com for HUMIRA® patients. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html

Commercial insurance coverage varies by type and plan. Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ® (upadacitinib) or HUMIRA® (adalimumab) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ® (upadacitinib) or HUMIRA® (adalimumab) at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.

HOW TO ENROLL
PATIENTS IN
RINVOQ COMPLETE

Help patients get the support they need to start and stay
on track with their prescribed treatment

To enroll a patient in RINVOQ Complete:

1

Download the enrollment & prescription form for your specialty

2

Fill out the form with your patient

  • This form enrolls your patient and can be used to initiate a prescription with your patient’s preferred specialty pharmacy.
  • The RINVOQ Complete Prescription section may help your commercially insured patients get access to RINVOQ if they experience a delay or denial in their insurance coverage.*
3

Fax the form to 1-678-727-0690

  • You will receive a call from an Access Specialist to discuss next steps.
  • If using the Pharmacy Prescription section, fax a copy to your patient’s specialty pharmacy as well.
4

Inform your patient that they have been enrolled

  • Let your patient know to expect a call from their Nurse Ambassador.

*Commercial insurance coverage varies by type and plan. Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ® (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ® (upadacitinib) at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.

Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment‑related questions, including further referrals.

COMPLETE APP

Track treatment

The Complete App helps patients stay on track with their prescribed RINVOQ or HUMIRA treatment by helping them:

  • Access additional resources, including a savings card for those that are eligible
  • Set customized medication reminders
  • Log symptoms
  • Log medication lot number and medication expiration date
Download on the App Store
Get it on Google Play

COMPLETEPRO.COM

Streamline the Rx process

CompletePro.com enables seamless enrollment into RINVOQ Complete and HUMIRA Complete, and helps streamline the prescription process for your patients.

With CompletePro.com, you can:

  • Request benefits verifications
  • Complete and submit prior authorizations
  • Send prescriptions to the patient’s specialty pharmacy of choice, with the option to include a savings card
  • Receive alerts for annual reauthorizations and renewals
  • Track and monitor where patients are in the prescription process

Learn more about streamlining the prescription process with Complete Pro:

Register now at

Downloadable Resources

Download RINVOQ resources to support your
patients and your practice.

RINVOQ SAFETY DATA

Review the safety profile of RINVOQ,
including both short- and long-term analyses